PEB:ASX
Pacific Edge Ltd
A$0.22
0.00%
(0.00) 1D
Nov 16, 1:22:05 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PEB...
Mkt. cap
342.94M
Avg. vol.
54.38K
Volume
0.00
52-wk high
A$0.26
52-wk low
A$0.12
No. of employees
114
Mkt. cap
342.94M
Avg. vol.
54.38K
Volume
0.00
52-wk high
A$0.26
52-wk low
A$0.12
No. of employees
114
News stories
From web sources and news partners
BigGo Finance
·
39 minutes ago
Wall Street Split on 2027 S&P 500 Outlook: Wells Fargo's 8,200 vs. Morgan Stanley's 8,700
TV News Check
·
1 hour ago
Dow Drops 849, Nasdaq Sinks 181, S&P 500 Falls 76
Investing.com
·
1 hour ago
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.64%
Traders Union
·
1 hour ago
Ryan Detrick: Technology stocks outperformed S&P 500 while 75 stocks declined
Profile
Pacific Edge Limited, based in New Zealand, focuses on cancer diagnostics with a suite of bladder cancer diagnostic tools using genetic biomarkers. The company operates with a head office in Dunedin, New Zealand, and also has an office in Hershey, USA. It is listed on the Australian ASX and the New Zealand NZX main board stock exchange. Wikipedia
About Pacific Edge Ltd
CEO-
Employees114
Founded2001
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitepacificedgedx.com